Advertisement

Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening

  • J. Waldmann
  • D. K. Bartsch
  • P. H. Kann
  • V. Fendrich
  • M. Rothmund
  • P. LangerEmail author
Original Article

Abstract

Background

Adrenal tumors are a common manifestation of the multiple endocrine neoplasia type 1 (MEN-1) syndrome. Prevalence in recent studies varies between 9 and 45%. A genotype–phenotype correlation has been described as well as the development of adrenocortical carcinomas. Long-term prospective data are still lacking.

Materials and methods

Thirty-eight MEN-1 patients with proven germline mutations have been prospectively observed in a regular screening program in our hospital. Adrenal glands have been screened by biochemical analysis and either by endoscopic ultrasound (EUS) or computed tomography (CT) or both. Median follow-up was 48 months (12–108 months). Age at diagnosis of MEN-1, type of adrenal tumor, genotype, therapy, and clinical characteristics have been analyzed.

Results

In 21 (55%) patients, adrenal involvement of the disease was detected. Adrenal lesions were detected in average 6.9 years after the initial diagnosis of MEN-1. Median tumor size was 12 mm (5–40 mm). Tumor size smaller than 10 mm was observed in 11 patients. Twelve patients had unilateral while nine had bilateral adrenal lesions. EUS detected all adrenal tumors, whereas CT failed in seven cases. In three patients, functioning tumors (one pheochromocytoma, one bilateral Cushing adenoma, and one adrenocortical carcinoma) and one nonfunctioning adenoma were diagnosed by histology and biochemical assessment. Two laparoscopic adrenalectomies and one laparoscopic subtotal resection were performed. Nonfunctioning adrenal lesions, not characterized by histology yet, were found in 18 patients. There was no statistical difference with regard to adrenal involvement between patients with germline mutations in exons 2 and 10 (12/21) and those with mutations in exons 3–9 (6/11).

Conclusion

MEN-1-associated adrenal tumors are mostly small, benign, and nonfunctioning and much more common than previously reported. EUS was the most sensitive imaging procedure. The genotype–pheotype correlation previously suggested by our group could not be confirmed.

Keywords

Adrenal lesion Multiple endocrine neoplasia type 1 Screening 

References

  1. 1.
    Chandrasekharappa SC et al (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311):404–407PubMedCrossRefGoogle Scholar
  2. 2.
    Wermer P (1954) Genetic aspects of adenomatosis of endocrine glands. Am J Med 16:363–371PubMedCrossRefGoogle Scholar
  3. 3.
    Burgess JR, Greenaway TM, Shepherd JJ (1998) Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1. J Intern Med 243(6):465–470PubMedCrossRefGoogle Scholar
  4. 4.
    Darling TN et al (1997) Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 133(7):853–857PubMedCrossRefGoogle Scholar
  5. 5.
    Duh QY et al (1987) Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg 154(1):142–148PubMedCrossRefGoogle Scholar
  6. 6.
    Gibril F et al (2003) Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 88(3):1066–1081PubMedCrossRefGoogle Scholar
  7. 7.
    Hofmann M et al (1998) Multiple endocrine neoplasia associated with multiple lipomas. Med Klin (Munich) 93(9):546–549CrossRefGoogle Scholar
  8. 8.
    Marx S et al (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129(6):484–494PubMedGoogle Scholar
  9. 9.
    Lips CJ, Vasen HF, Lamers CB (1984) Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol 2(2):117–184PubMedGoogle Scholar
  10. 10.
    Thakker RV (2000) Multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 29(3):541–567PubMedCrossRefGoogle Scholar
  11. 11.
    Carty SE et al (1998) The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124(6):1106–1113; discussion 1113–4PubMedCrossRefGoogle Scholar
  12. 12.
    Skogseid B et al (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75(1):76–81PubMedCrossRefGoogle Scholar
  13. 13.
    Skogseid B et al (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118(6):1077–1082PubMedCrossRefGoogle Scholar
  14. 14.
    Burgess JR et al (1996) Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 131(7):699–702PubMedGoogle Scholar
  15. 15.
    Langer P et al (2002) Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg 26(8):891–896PubMedCrossRefGoogle Scholar
  16. 16.
    Barzon L et al (2001) Multiple endocrine neoplasia type 1 and adrenal lesions. J Urol 166(1):24–27PubMedCrossRefGoogle Scholar
  17. 17.
    Gibril F et al (2004) Multiple endocrine neoplasia type 1 and Zollinger–Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine (Baltimore) 83(1):43–83CrossRefGoogle Scholar
  18. 18.
    Cadiot G et al (1999) Prognostic factors in patients with Zollinger–Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d’Etude des Neoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d’Etude du Syndrome de Zollinger–Ellison (GRESZE). Gastroenterology 116(2):286–293PubMedCrossRefGoogle Scholar
  19. 19.
    Ballard HS, Fame B, Hartstock RJ (1964) Familial endocrine adenoma-peptic ulcer complex. Medicine (Baltimore) 43:481–516CrossRefGoogle Scholar
  20. 20.
    Croisier JC, Azerad E, Lubetzki J (1971) L’adenomatose polyendocrinienne (syndrome de Wermer). Semin Hop Paris 47:494–525Google Scholar
  21. 21.
    Dobbie JW (1969) Adrenocortical nodular hyperplasia: the ageing adrenal. J Pathol 99:1–18PubMedCrossRefGoogle Scholar
  22. 22.
    Kokko JP, Brown TC, Berman MM (1967) Adrenal adenoma and hypertension. Lancet 1(7488):468–470PubMedCrossRefGoogle Scholar
  23. 23.
    Hedeland H, Ostberg G, Hokfelt B (1968) On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand 184(3):211–214PubMedGoogle Scholar
  24. 24.
    Anonymous (2002) NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements 19(2):1–25Google Scholar
  25. 25.
    Thompson GB, Young WF Jr (2003) Adrenal incidentaloma. Curr Opin Oncol 15(1):84–90CrossRefGoogle Scholar
  26. 26.
    Kloos RT et al (1997) Diagnostic dilemma of small incidentally discovered adrenal masses: role for 131I-6beta-iodomethyl-norcholesterol scintigraphy. World J Surg 21(1):36–40PubMedCrossRefGoogle Scholar
  27. 27.
    Commons RR, Callaway CP (1948) Adenomas of the adrenal cortex. Arch Intern Med 81:37–41Google Scholar
  28. 28.
    Reinhard C, Saeger W, Schubert B (1996) Adrenocortical nodules in post-mortem series. Development, functional significance, and differentiation from adenomas. Gen Diagn Pathol 141(3–4):203–208PubMedGoogle Scholar
  29. 29.
    Granger P, Genest J (1970) Autopsy study of adrenals in unselected normotensive and hypertensive patients. Can Med Assoc J 103(1):34–36PubMedGoogle Scholar
  30. 30.
    Brandi ML et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86(12):5658–5671PubMedCrossRefGoogle Scholar
  31. 31.
    Skogseid B et al (1996) Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 20(7):872–876; discussion 877PubMedCrossRefGoogle Scholar
  32. 32.
    Brandi ML et al (1987) Familial multiple endocrine neoplasia type I: a new look at pathophysiology. Endocr Rev 8(4):391–405PubMedCrossRefGoogle Scholar
  33. 33.
    Trump D et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q J Med 89(9):653–669Google Scholar
  34. 34.
    Chico A et al (2000) Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type I. Endocr Pract 6(1):13–19PubMedGoogle Scholar
  35. 35.
    Agarwal SK et al (1999) Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96(1):143–152PubMedCrossRefGoogle Scholar
  36. 36.
    Kim YS et al (1999) Stable overexpression of MEN1 suppresses tumorigenicity of RAS. Oncogene 18(43):5936–5942PubMedCrossRefGoogle Scholar
  37. 37.
    Heppner C et al (2001) The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 20(36):4917–4925PubMedCrossRefGoogle Scholar
  38. 38.
    Zwermann O et al (2000) Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. Eur J Endocrinol 142(6):689–695PubMedCrossRefGoogle Scholar
  39. 39.
    Schulte KM et al (1999) MEN I gene mutations in sporadic adrenal adenomas. Hum Genet 105(6):603–610PubMedCrossRefGoogle Scholar
  40. 40.
    Gortz B et al (1999) MEN1 gene mutation analysis of sporadic adrenocortical lesions. Int J Cancer 80(3):373–379PubMedCrossRefGoogle Scholar
  41. 41.
    Heppner C et al (1999) MEN1 gene analysis in sporadic adrenocortical neoplasms. J Clin Endocrinol Metab 84(1):216–219PubMedCrossRefGoogle Scholar
  42. 42.
    Crabtree JS et al (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98(3):1118–1123PubMedCrossRefGoogle Scholar
  43. 43.
    Tomassetti P et al (1995) Chromosomal instability in multiple endocrine neoplasia type 1. Cytogenetic evaluation with DEB test. Cancer Genet Cytogenet 79(2):123–126PubMedCrossRefGoogle Scholar
  44. 44.
    Scappaticci S et al (1992) Cytogenetics of multiple endocrine neoplasia syndrome. II. Chromosome abnormalities in an insulinoma and a glucagonoma from two subjects with MEN1. Cancer Genet Cytogenet 63(1):17–21PubMedCrossRefGoogle Scholar
  45. 45.
    Pannett AA, Thakker RV (2001) Somatic mutations in MEN type 1 tumors, consistent with the Knudson “two-hit” hypothesis. J Clin Endocrinol Metab 86(9):4371–4374PubMedCrossRefGoogle Scholar
  46. 46.
    Bartsch DK et al (2000) Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery 128(6):958–966PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • J. Waldmann
    • 1
  • D. K. Bartsch
    • 2
  • P. H. Kann
    • 3
  • V. Fendrich
    • 1
  • M. Rothmund
    • 1
  • P. Langer
    • 1
    • 4
    Email author
  1. 1.Department of General SurgeryPhilipps-UniversityMarburgGermany
  2. 2.Department of SurgeryStädtische Kliniken BielefeldBielefeldGermany
  3. 3.Division of Endocrinology and DiabetologyPhilipps-UniversityMarburgGermany
  4. 4.Department of SurgeryPhilipps-University HospitalMarburgGermany

Personalised recommendations